TheHill is Oxford University Hospitals NHS Foundation Trust (OUH) Innovation service which empowers innovation in health and care by supporting new approaches which seek to make the NHS more efficient and effective, empowering staff…
Continue Reading
Kneu Health (formerly Neu Health), a University of Oxford spinout, delivers AI-powered digital health solutions for neurology, focusing on Parkinson’s and dementia. This FDA-cleared, UKCA-marked platform integrates a patient app and clinician dashboard. Backed…
Continue Reading
Dr Helen Ashdown, NHS GP and National Institute for Health and Care Research (NIHR) academic clinical lecturer at the University of Oxford (Credit: Nasir Hamid)
A University of Oxford study will assess whether an…
Continue Reading
Oxford University spin-out OrganOx has been acquired by Terumo Corporation in a $1.5bn (£1.2bn) deal, representing one of the largest exits of a UK MedTech company.
The firm, founded by Constantin Coussios and Peter Friend,…
Yolande Pengetnze, MD, MS, SVP of Clinical Leadership at PCCI
If you are leading efforts to improve and understand public health in your community, we’ve researched and validated that PCCI’s Community Vulnerability Compass (CVC) offers an…
Continue Reading
Ultromics, a provider of AI-driven cardiology solutions, has raised $55 million (£41m) in Series C financing to scale its technology across the US.
Founded out of the University of Oxford, Ultromics offers the first FDA-cleared…
What You Should Know:
– Ultromics, a pioneer in AI-driven cardiology solutions secures $55M in Series C financing co-led by L&G, Allegis Capital, and Lightrock, with continued support from Oxford Science Enterprises, GV, Blue Venture…
Continue Reading
What You Should Know:
– NVIDIA Research, in collaboration with the University of Oxford and Mila – Québec AI Institute, has unveiled La-Proteina, a novel method for atomistic protein design.
– Published on arXiv on July…
Continue Reading
Memorial Sloan Kettering Cancer Center and UnitedHealthcare are locked in a high-stakes contract negotiation that could significantly impact cancer patients across the region. The renowned cancer treatment facility has issued warnings to patients about…
Continue Reading
What You Should Know:
– Oxford Cancer Biomarkers Ltd (OCB), a leader in molecular precision cancer diagnostic tests, has today announced a new partnership with Mira Precision Health Inc.
– This collaboration aims to advance OCB’s…
Continue Reading
